When a large pharmaceutical company wanted to release a new drug, it did not market it by sending samples to doctors. Instead, it launched it on a social networking platform for doctors. “ By the virtue of an online launch, we created awareness about the drug through educational videos that reached over 2,00,000 doctors, and those who wanted samples or more information about the drug posted enquiries on the Curofy platform ,” said Nipun Goyal, cofounder of Curofy, the Roundglass Partners-backed social networking platform for doctors that counts Abbott Laboratories, Cipla and Phi lips among clients. Platforms such as Curofy, Daily Rounds and Docplexus are helping device makers and pharma companies reduce cost overheads by enhancing the efficiency of medical representatives and helping them connect with doctors. While digital marketing for pharmaceuticals is the main source of revenue generation for these platforms, what makes them interesting is that these platforms are help...